Interpreting Diabetic Retinal Outcomes After GLP-1 Receptor Agonist and Tirzepatide Initiation: Clinical Evidence and Its Limits

Diabetes, obesity & metabolism · 2026 Oct 27 · Wu B, He BS et

By Maren Holt · Senior Reporter, GLP-1

Oct 26 20:00 ETSource: Diabetes, obesity & metabolism

From the source

Interpreting Diabetic Retinal Outcomes After GLP-1 Receptor Agonist and Tirzepatide Initiation: Clinical Evidence and Its Limits
Diabetes, obesity & metabolism · 2026 Oct 27 · Wu B, He BS et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42946946/